MARKER FOR DIAGNOSING DIABETIC RETINOPATHY AND USE THEREOF

摘要

PURPOSE: A composition for diagnosing diabetic retinopathy containing an agent which measures gene or protein level of AGP(alpha-1 acid glycoprotein) or PEDF(pigment epithelium-derived factor) is provided to simply and early diagnose diabetic retinopathy. CONSTITUTION: A composition for diagnosing diabetic retinopathy contains an agent which measures mRNA or protein level of AGP or PEDF. A composition for diagnosing diabetic retinopathy contains an agent which measures mRNA or protein level of APOC1(apolipoprotein C1), APOB100(apolipoprotein B100), APOC3(apolipoprotein C3), APOB 100(apolipoprotein B100), APOC 3(apolipoprotein C3), CP(ceruloplasmin), or CFB(complement factor B). A method for providing information for diagnosing diabetic retinopathy comprises: a step of measuring gene or protein expression level of AGP or PEDF from a biological sample; and a step of comparing the expression level with the expression level of a normal control group.